Lydia G. G.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase 2 Study of ACR-368 and Gemcitabine in Subjects with Endometrial Cancer
- Phase 3 Study Comparing Rinatabart Sesutecan Versus Investigator's Choice in Patients With Recurrent or Progressive Endometrial Cancer Following Platinum-Based and PD(L)-1 Therapy
Data & Insights
Has run more than one trial at 197 of 345 partner sites.
Specializations
Ovarian Cancer Research
This investigator specializes in treating platinum-resistant high-grade ovarian cancer and related conditions including fallopian tube and primary peritoneal cancers. Their work extends to studying homologous recombination deficiency in advanced ovarian cancer cases.
- Advanced stage treatment approaches
- Maintenance therapy strategies
- Novel therapeutic combinations
Endometrial Cancer Studies
The investigator conducts research on advanced and recurrent endometrial cancer, with particular focus on maintenance therapies and combination treatment approaches. Their work includes evaluation of both early-stage and advanced disease management.
- Post-surgery treatment protocols
- Immunotherapy applications
- High-risk disease management
Cervical Cancer Expertise
Research focus includes locally advanced cervical cancer and metastatic cervical carcinoma. The investigator studies innovative therapeutic approaches for both early-stage and advanced disease states.
- Treatment resistance patterns
- Combination therapy approaches
- Advanced stage interventions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.